Abbott Laboratories ABT

Abbott Laboratories is a publicly traded company listed on NYSE under the ticker ABT. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; car

Abbott Laboratories (ABT) is trading at $85.60, down 0.81% on the day. Prices on this page update through the trading session. This is not financial advice.

Wall Street analysts currently rate ABT a consensus "Buy", with an average 12-month price target of $118.32 (+38.22% vs the current price). Ratings are opinions, not guarantees — always do your own research.

The next Abbott Laboratories earnings date is around Apr 16, 2026. Earnings dates can move — check the company's investor relations page to confirm.

Abbott Laboratories pays a dividend with a current yield of about 2.94% ($2.52 per share annually).